Pengfei Lei
Central South University
35 Papers
36 Citations
Pengfei Lei is an academic researcher from Central South University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 8, co-authored 16 publications.
Chat about Author
Papers
LncRNA MALAT1 shuttled by bone marrow-derived mesenchymal stem cells-secreted exosomes alleviates osteoporosis through mediating microRNA-34c/SATB2 axis.
Yang Xucheng,Yang Junxiao,Pengfei Lei,Ting Wen +3 more
- 26 Oct 2019
TL;DR: It is demonstrated that BMSCs-derived exosomal MALAT1 enhances osteoblast activity in osteoporotic mice by mediating the miR-34c/SATB2 axis.
Bone Defects in Revision Total Knee Arthroplasty and Management.
Pengfei Lei,Ruyin Hu,Yihe Hu +2 more
TL;DR: The overall outcome of RTKA is not as satisfactory as for primary TKA due to the uncertainty regarding the actual success rate and the risk factors for failure.
101
Free vascularized iliac bone flap based on deep circumflex iliac vessels graft for the treatment of osteonecrosis of femoral head
Pengfei Lei,Wei Du,Hao Liu,Panfeng Wu,Zhengbing Zhou,Fang Yu,Liming Qing,Ding Pan,Rui Liu,Lei Zeng,Zheming Cao,Ou Qifeng,Juyu Tang +12 more
TL;DR: Free vascularized iliac bone flap based on deep circumflex iliAC vessels graft is an acceptable treatment option for young adult ONFH in mid-late stage with low conversion to THA rate at short-term follow-up.
Fabrication, bacteriostasis and osteointegration properties researches of the additively-manufactured porous tantalum scaffolds loading vancomycin
Hu Qian,Ting Lei,Long Hua,Yu Shrike Zhang,Dongyu Wang,Jiangyu Nan,Wenbin Liu,Yan Sun,Yihe Hu,Pengfei Lei +9 more
TL;DR: In this paper , vancomycin (Van) was encapsulated into poly(lactic co-glycolic acid) (PLGA) microspheres through the double emulsion method, which were then loaded into the additively-manufactured porous tantalum (AM-Ta) through gelatin methacryloyl (GelMA) hydrogel to produce the composite Ta/Gel/PLGA/vancomycin(Van) scaffolds for repairing IBDs.
24
MicroRNA-133b inhibits the migration and invasion of non small cell lung cancer cells via targeting FSCN1.
TL;DR: The present study suggests that miR-133b inhibits the migration and invasion of NSCLC cells via directly targeting FSCN1, and thus may be used for the treatment ofNSCLC metastasis.